Now that the Waiver Elimination (MAT Act) eliminated the need for providers to obtain an X waiver to prescribe buprenorphine for opioid use disorder, my understanding is that buprenorphine should be like any other drug.
Does this mean that the 3-day rule for patients that present to a hospital for opioid withdrawal now applies only to methadone, but not to buprenorphine?
Have other organizations relaxed the rules for buprenorphine use, or do you have a different interpretation on how this legal change affects hospitals?
(See https://www.samhsa.gov/medications-substance-use-disorders/waiver-elimin...)